VOZ Perspectives

THE VOZ ADVISORS BLOG


Our Latest Blogs

October 7, 2026

Patient engagement is important in all drug development, but it becomes especially critical and fundamentally…

October 13, 2026

As discussions around MFN policy continue to evolve, a fundamental question remains: how can we…

October 2, 2026

With a background in patient-focused leadership, we’re excited to welcome Helen Klein to the VOZ…

June 29, 2026

Richard Klein, photographed during his tenure at the Food and Drug Administration in the 1990s.…

May 28, 2026

From the outside, my story doesn’t start with illness, it starts with motion. Growing up,…

March 26, 2026

Nearly 70% of pregnant women take at least one medication during pregnancy, yet fewer than…

March 26, 2026

For over 30 years, VOZ has partnered with biopharmaceutical teams in building and deepening relationships…